Literature DB >> 9266270

Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery.

A Wildfeuer1, J Mallwitz, H Gotthardt, E Hille, H Gruber, G Dahmen, G Pfaff, C Göbel.   

Abstract

As perioperative prophylaxis for major orthopedic operations 81 patients were given the fixed combination of ampicillin (1 g)/sulbactam (0.5 g) or cefotiam (2 g) as short infusions. The three beta-lactams were rapidly distributed into the different tissues and their pharmacokinetic profiles were found to be very similar. It was noteworthy that ampicillin, sulbactam and cefotiam penetrated within minutes, not only into skin, fat and muscles, but also into bone. Thus 0.25 h after starting the infusion the following mean concentrations were measured in bone: 21.8 +/- 10.5 mg/kg ampicillin, 4.9 +/- 2.2 mg/kg sulbactam and 19.4 +/- 10.6 mg/kg cefotiam. For a period of at least 2 h the concentrations measured in serum and in the different tissues affected by the operation (skin, fat, muscle, bone) were above the MICs for pathogens which are involved in postoperative wound infections. On the basis of pharmacokinetic data, ampicillin/sulbactam and cefotiam seem about equally suitable for perioperative prophylaxis in major orthopedic operations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266270     DOI: 10.1007/bf01713160

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.

Authors:  U Frank; F D Daschner
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

2.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections.

Authors:  L Löffler; A Bauernfeind; W Keyl
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.

Authors:  D S Kernodle; D C Classen; J P Burke; A B Kaiser
Journal:  JAMA       Date:  1990-02-16       Impact factor: 56.272

5.  Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery.

Authors:  A Wildfeuer; V Müller; M Springsklee; H G Sonntag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

6.  Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors:  W R Heizmann; F Heilmann; B Egeler; H Werner
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

7.  Antibiotic prophylaxis with two doses of cephalosporin in patients managed with internal fixation for a fracture of the hip.

Authors:  A Bodoky; U Neff; M Heberer; F Harder
Journal:  J Bone Joint Surg Am       Date:  1993-01       Impact factor: 5.284

  7 in total
  4 in total

1.  [Ampicillin and sulbactam concentrations in the irradiated mandible after oral squamous cell cancer].

Authors:  H Heibel; M Scheer; T Reuther; M Hahn; R Trittler; H Egle; K Kümmerer; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07

Review 2.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

Review 3.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

4.  Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis Following a Single Preoperative Dose.

Authors:  Philipp Poxleitner; Michael Andreas Ermer; Rainer Trittler; Carolin Lena Feuerstein; Jörg-Elard Otten; Rainer Schmelzeisen; Pit Jacob Voss; David Steybe
Journal:  Antibiotics (Basel)       Date:  2020-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.